Abstract:Objective: To determine the prevalence and the risk factors of diabetic peripheral neuropathy (DPN) in hospitalized adult Saudi diabetics. Methods: This is a retrospective, nested case-control study conducted at King Abdulaziz Medical City (KAMC) in Riyadh, Saudi Arabia. All diabetic patients admitted to the hospital between the January 1, and December 31, 2018 were considered for inclusion in the study. Patients with DPN were identified and three controls per case were randomly selected from the remaining dia… Show more
“…A recent study was performed among Hospitalized Diabetic Patients in Riyadh, Saudi Arabia and they found that only 3.5% of them had DPN. It is noticed that the reported prevalence of DPN is decreasing throughout the years; this might be due to the increase in the awareness of patients about glycemic control, which is a crucial factor in delaying the rate of development of DPN [21]. However, this disparity in prevalence could be due to the difference in populations and the methods of data collection since some studies have used clinically based methods for the diagnosis, while others like this one have used questionnaire-based methods.…”
Section: Resultsmentioning
confidence: 99%
“…This might be because the doctors were not aware of the DPN or they have considered it as part of the regular progression and the natural history of diabetes and not as a complication, this might indicate a lack of awareness among doctors about DPN, which will require serious intervention to raise their awareness about this issue. One of the limitations of this study is that it did not investigate the presence of risk factors for DPN among the participants, risk factors such as BMI, poor glycemic control, and other comorbidities (dyslipidemia, peripheral vascular disease, hypertension, and chronic kidney disease), have been significantly associated with DPN [21]. Another limitation is that only a questionnaire-based assessment for DPN was made and was not combined with clinical assessment.…”
Diabetic Peripheral Neuropathy (DPN) and restless leg syndrome are common among patients with diabetes and might complicate each other's deleterious consequences. The study assessed the rates of peripheral neuropathy and restless leg syndrome in diabetes mellitus. This study is a case-control carried out in king Fahad specialist hospital and primary healthcare centers in Tabuk city, Saudi Arabia during the period from September to December 2020, 132 diabetic patients were selected as cases, and 132 as controls. A structured, self-administered questionnaire based on the International Restless Leg Syndrome Study Group consensus criteria and Michigan peripheral neuropathy assessment questionnaire were used to obtain information from the participants. Moreover, the Statistical Package for Social Sciences (SPSS) software was used for data analysis. Out of 264 participants with a mean age (46 ± 14 years), males' dominance was obvious (73.5% and 75.0% in patients and the control group, respectively). Peripheral neuropathy was evident in 18.2% of patients and 2.3% of the control group, P-value < 0.001). Ninety-one of the participants in both of the study groups had restless leg syndrome, out of which 53.9% were from the diabetes mellitus group. No significant association was found between having restless leg syndrome with neither peripheral neuropathy nor diabetes mellitus, p values: 0.524, and 0.822, respectively. Peripheral neuropathy and restless leg syndrome were common among patients with diabetes, however, no significant association was found between restless leg syndrome with neither diabetes nor peripheral neuropathy; So, raising the awareness of the public and clinicians is highly needed.
“…A recent study was performed among Hospitalized Diabetic Patients in Riyadh, Saudi Arabia and they found that only 3.5% of them had DPN. It is noticed that the reported prevalence of DPN is decreasing throughout the years; this might be due to the increase in the awareness of patients about glycemic control, which is a crucial factor in delaying the rate of development of DPN [21]. However, this disparity in prevalence could be due to the difference in populations and the methods of data collection since some studies have used clinically based methods for the diagnosis, while others like this one have used questionnaire-based methods.…”
Section: Resultsmentioning
confidence: 99%
“…This might be because the doctors were not aware of the DPN or they have considered it as part of the regular progression and the natural history of diabetes and not as a complication, this might indicate a lack of awareness among doctors about DPN, which will require serious intervention to raise their awareness about this issue. One of the limitations of this study is that it did not investigate the presence of risk factors for DPN among the participants, risk factors such as BMI, poor glycemic control, and other comorbidities (dyslipidemia, peripheral vascular disease, hypertension, and chronic kidney disease), have been significantly associated with DPN [21]. Another limitation is that only a questionnaire-based assessment for DPN was made and was not combined with clinical assessment.…”
Diabetic Peripheral Neuropathy (DPN) and restless leg syndrome are common among patients with diabetes and might complicate each other's deleterious consequences. The study assessed the rates of peripheral neuropathy and restless leg syndrome in diabetes mellitus. This study is a case-control carried out in king Fahad specialist hospital and primary healthcare centers in Tabuk city, Saudi Arabia during the period from September to December 2020, 132 diabetic patients were selected as cases, and 132 as controls. A structured, self-administered questionnaire based on the International Restless Leg Syndrome Study Group consensus criteria and Michigan peripheral neuropathy assessment questionnaire were used to obtain information from the participants. Moreover, the Statistical Package for Social Sciences (SPSS) software was used for data analysis. Out of 264 participants with a mean age (46 ± 14 years), males' dominance was obvious (73.5% and 75.0% in patients and the control group, respectively). Peripheral neuropathy was evident in 18.2% of patients and 2.3% of the control group, P-value < 0.001). Ninety-one of the participants in both of the study groups had restless leg syndrome, out of which 53.9% were from the diabetes mellitus group. No significant association was found between having restless leg syndrome with neither peripheral neuropathy nor diabetes mellitus, p values: 0.524, and 0.822, respectively. Peripheral neuropathy and restless leg syndrome were common among patients with diabetes, however, no significant association was found between restless leg syndrome with neither diabetes nor peripheral neuropathy; So, raising the awareness of the public and clinicians is highly needed.
“…Changes of plasma concentration and structural modi cation of albumin induced by high glucose or free radicals impair its antioxidant properties and aggravate oxidative stress [19]. Several previous studies have explored the association of serum albumin with the development of DPN, and provided inconsistent results [12][13][14][15]. Iwasaki et al reported that serum albumin was independently related to the median motor nerve conduction velocity and minimum F-wave latency in 130 Japanese patients with T2DM, and was signi cantly inversely associated with the presence of DPN [12].…”
Section: Discussionmentioning
confidence: 99%
“…Data from a cross-sectional study of 409 Chinese patients with T2DM underwent measurement of nerve conduction (NC) showed that serum albumin was independently associated with peripheral nerve function as re ected by composite Z scores of all NC parametersin T2DM patients, especially in those with albuminuria [13]. Recently reported data from the Saudi study, which included 2,906 hospitalized adult diabetics, demonstrated that DPN cases had a signi cantly lower serum albumin levels compared with those without DPN [14]. However, no statistically signi cant association between serum albumin and DPN in US patients undergoing foot and ankle surgery with a history of Type 1 and 2 diabetes mellitus over a 13 month period [15].…”
Section: Discussionmentioning
confidence: 99%
“…There is considerable evidence indicated that serum albumin has a wide range of physiological functions, including antioxidant, anti-in ammatory, anticoagulant, antiplatelet aggregation activity, regulating immune response, preventing endothelial cell, Schwann cells and neuronal apoptosis, dilating blood vessel, protecting against neuronal injury from ischemia and reperfusion, and improving neuronal functional recovery [4][5][6][7][8][9][10][11], suggesting that albumin may confer robust neuroprotection, and lower levels of serum albumin may be involved in the development of DPN. Although few observations have suggested presence of such a link [12][13][14], others have reported the lack of an independent association [15]. Such discrepancy in the literature may be due to differences in study population, diabetic duration, a limitation in the diversity of selected participants, diagnostic methods for DPN, variation in design, limitations in sample size, and a limited range in which serum albumin has been studied.…”
Background: Studies that investigated the association between serum albumin and the risk of diabetic peripheral neuropathy (DPN) have reported inconsistent results. The objective of this study was to explore the relationship between serum albumin and DPN in Chinese patients with type 2 diabetes mellitus (T2DM). Methods: Serum albumin levels were measured in 1465 patients with T2DM aged 16–89 years. The relationships between serum albumin and the prevalence of DPN and other parameters were analyzed. Results: Patients in the highest quartile of serum albumin had lower prevalence of DPN compared with subjects in the lowest quartile (P <0.01). Serum albumin was positively associated with DBP, total cholesterol, triglycerides, high-density lipoprotein cholesterol, uric acid, and negatively with glycated hemoglobin A1c, γ-glutamyltransferase, cystatin C, serum creatinine, albumin- to-creatinine ratio, neutrophil-to-lymphocyte ratio, vibration perception thresholds (VPT), and prevalence of DPN after adjustments for age, gender, body mass index, and diabetic duration ( P<0.01 or P<0.05). There was an 50.1% decreased risk of DPN (95% confidence interval [CI] 0.404-0.544; P <0.01) per 1 SD increase of serum and 62.7% decreased risk of DPN in quartile 4 of serum albumin versus quartiles 1, 2, and 3 (95% CI 0.195-0.714; P=0.003) after multivariate adjustment. Serum albumin could predict DPN with 65.88% sensitivity and 66.7% specificity for the best cutoff value of 39.95 g/L. Conclusions: These findings suggest that lower serum albumin might be associated with the presence of DPN via increased oxidative stress, inflammation, and vasculopathy. Further larger and prospective studies are needed to confirm our findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.